Acorda Therapeutics completes sales foce expansion

Share this content:
Acorda Therapeutics has completed the expansion of its sales force to 65 people, with 52 area business managers, calling on specialists and primary care physicians. The sales team promotes Zanaflex Capsules (tizanidine hydrochloride), a short-acting drug for the management of spasticity.

Share this content:
Scroll down to see the next article